Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) announced a private placement of up to 84,000,000 shares at not less than CNY 15.83 per share for gross proceeds of up to CNY 1,329,720,000 on November 30, 2015. The transaction will include participation from 10 designated investors. The transaction has been approved in the 23rd session of the 5th directorate of the company.

The transaction is subject to approval from the company shareholders and the China Securities Regulatory Commission.